• ryanjamesjessup

Imaging Diagnostics Consulting | Late Phase

Updated: Apr 28

Medical imaging visually represents the interior of a body, as well as the function of organs or tissues.

Diagnostic imaging is a core competency of BioMolecular Imaging because we have an extensive background in the clinical use of anatomic and molecular imaging technologies - especially novel imaging probe development from the molecule to human imaging. These areas of expertise extend across therapeutic areas, organ systems, and probe types, including small molecules, peptides and antibodies.

“Late phase trials for new diagnostic agents is a key focus as well, whether for diagnostic agents developed alone or in combination with a therapeutic agent.” - Dr. J. James Frost, Owner of BioMolecular Imaging

With a deep and long standing experience in clinical radiology and nuclear medicine, we help you design a pivotal trial that will lay a foundation for rapid extension into clinical practice. Formulation of clinical reader training protocols is also part of this process, especially given the current Food and Drug Administration approval criteria for new commercial diagnostic imaging agents.

We also have experience in strategies and protocols for “gold standard” comparison and validation, which in terms of organizing and chairing advisory board meetings, can help your company assemble the best experts for phase III and IV planning, product rollout and rapid adoption.

Decades of front-line clinical imaging experience will ensure the formulation of a practical and compelling implementation plan for routine patient use.

About BioMolecular Imaging

BioMolecular Imaging (BMI Consultants) is a molecular imaging and clinical trial consultancy owned and operated by Dr. J. James Frost M.D./Ph.D out of Baltimore Maryland. BMI has been involved with clinical, therapeutic & diagnostic imaging focused on Oncology, Brain, Biomarkers, Cardiology and Central Image Interpretations for over 20 years.

To learn more about BioMolecular Imaging, please visit or connect with:

SoundCloud -

Facebook -

Twitter -

LinkedIn -

YouTube -

Copyright © 2022 BioMolecular Imaging

BioMolecular Imaging is a registered trademark of BioMolecular Imaging D.B.A. BMI Consultants

20 views0 comments

Recent Posts

See All

Diagnostic imaging is a core competency of BioMolecular Imaging - and is the approach of imaging the human body to analyze and form medical intervention, especially when viewing the function of organs

Imaging in therapeutic trials is the key process in expanding the understanding, methodology and metrics which are required to make determinations in drug targeting and efficacy. This spans most all i

A very active area of current investigation and commercialization is molecular and functional biomarker development. These biomarkers can serve as surrogate endpoints for therapeutic efficacy and are